<p>(A) Annexin V-PE labelling of MCF-7aro cells treated with exemestane (15 µM) for 6 and 9 days of treatment. Cells cultured with T were considered as control and for 6 days present 3.54% and for 9 days 5.58% of Annexin V binding. Data presented in histograms were analysed with FlowJo Software (Tree Star, Inc), correspond to cells gated for negative 7-AAD staining and are representative of one independent assay. The grey filled line corresponds to control and the black line to exemestane at 15 µM. (B) Mitochondrial transmembrane potential (ΔΨm) of MCF-7aro cells treated with exemestane (15 µM) with or without 3-MA (1 mM), for 3 and 6 days. Viable cells and cells with ΔΨm loss were identified. Data presented in histograms were analysed with...
<p>A. Annexin V-PE binding in HEK293T cells i) untransfected cells, ii) cells transfected with 4 µg ...
<p>MCF7 (cancer) and MCF10 (non-tumorigenic) cells were treated with the PEMF paradigms producing th...
<p>Cells were treated with either 1 μM englerin A or carrier DMSO for 60 min, or 5 μM staurosporine ...
<p>Cells were treated with different concentrations of exemestane with or without 1 mM of 3-MA after...
<p>Cells were treated with different concentrations of exemestane for 6 and 9 days. Treated cells we...
<p>To study cell viability (A, B) and cell proliferation (C), cells were treated with different conc...
<p>Endometrial cancer cells were treated with 100 μM of telmisartan for 48 h. Cells were then staine...
(A) hTERT-HUVECs were treated with mock labeled EV. (B) hTERT-HUVECs were treated with mock labeled ...
<p>A. Annexin V-PE binding in HEK293T cells i) untransfected cells, ii) cells transfected with 4 µg ...
<p>Cells were treated with different concentrations of exemestane after 3, 6 and 9 days. Cells with ...
<p>(a) Images show immunocytochemical staining of Annexin V and propidium iodide (PI) staining in EP...
<p>TIME annexin A2 shRNA2 and scramble (control) cells were plated on microscope cover slips and inc...
<p>(A) JC-1 assay for detection of the mitochondrial membrane potential at 24 h of TG or TM treatmen...
Labeled annexin V is widely used to detect cell death in vitro and in vivo. Nearly all studies have ...
The cell death mechanism was studied after double staining of cells with annexin V-FITC and PI and m...
<p>A. Annexin V-PE binding in HEK293T cells i) untransfected cells, ii) cells transfected with 4 µg ...
<p>MCF7 (cancer) and MCF10 (non-tumorigenic) cells were treated with the PEMF paradigms producing th...
<p>Cells were treated with either 1 μM englerin A or carrier DMSO for 60 min, or 5 μM staurosporine ...
<p>Cells were treated with different concentrations of exemestane with or without 1 mM of 3-MA after...
<p>Cells were treated with different concentrations of exemestane for 6 and 9 days. Treated cells we...
<p>To study cell viability (A, B) and cell proliferation (C), cells were treated with different conc...
<p>Endometrial cancer cells were treated with 100 μM of telmisartan for 48 h. Cells were then staine...
(A) hTERT-HUVECs were treated with mock labeled EV. (B) hTERT-HUVECs were treated with mock labeled ...
<p>A. Annexin V-PE binding in HEK293T cells i) untransfected cells, ii) cells transfected with 4 µg ...
<p>Cells were treated with different concentrations of exemestane after 3, 6 and 9 days. Cells with ...
<p>(a) Images show immunocytochemical staining of Annexin V and propidium iodide (PI) staining in EP...
<p>TIME annexin A2 shRNA2 and scramble (control) cells were plated on microscope cover slips and inc...
<p>(A) JC-1 assay for detection of the mitochondrial membrane potential at 24 h of TG or TM treatmen...
Labeled annexin V is widely used to detect cell death in vitro and in vivo. Nearly all studies have ...
The cell death mechanism was studied after double staining of cells with annexin V-FITC and PI and m...
<p>A. Annexin V-PE binding in HEK293T cells i) untransfected cells, ii) cells transfected with 4 µg ...
<p>MCF7 (cancer) and MCF10 (non-tumorigenic) cells were treated with the PEMF paradigms producing th...
<p>Cells were treated with either 1 μM englerin A or carrier DMSO for 60 min, or 5 μM staurosporine ...